Search research articles
Contact Us
Filters
Showing results (431-440 of 439) with videos related to
Page
of 44
Sort By:
You have reached the last page of results.
This site can display upto 439 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2015
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
Nathalie Gaspar, Douglas S Hawkins, Uta Dirksen, et al.
Pediatric Blood & Cancer
|
January 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial
Roberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano, et al.
The Lancet. Oncology
|
May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.
Cancer
|
February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)
Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
The Lancet. Oncology
|
July 24, 2019
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
Silvia Stacchiotti, Stefano Ferrari, Andres Redondo, et al.
Tumori
|
December 9, 2017
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma
Stefano Ferrari, Stefan S Bielack, Sigbjørn Smeland, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2021
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
Ivar Hompland, Stefano Ferrari, Stefan Bielack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2025
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials
Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
Clinical Sarcoma Research
|
June 18, 2016
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report
Leo Kager, Jeremy Whelan, Uta Dirksen, et al.
Page
of 44
Search research articles
Search
Showing results (431-440 of 439) with videos related to
Sort By:
Page
of 44
You have reached the last page of results.
This site can display upto 439 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2015
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
Nathalie Gaspar, Douglas S Hawkins, Uta Dirksen, et al.
Pediatric Blood & Cancer
|
January 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial
Roberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano, et al.
The Lancet. Oncology
|
May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.
Cancer
|
February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)
Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
The Lancet. Oncology
|
July 24, 2019
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
Silvia Stacchiotti, Stefano Ferrari, Andres Redondo, et al.
Tumori
|
December 9, 2017
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma
Stefano Ferrari, Stefan S Bielack, Sigbjørn Smeland, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2021
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
Ivar Hompland, Stefano Ferrari, Stefan Bielack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2025
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials
Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
Clinical Sarcoma Research
|
June 18, 2016
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report
Leo Kager, Jeremy Whelan, Uta Dirksen, et al.
Page
of 44